Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 6368780, 12 pages
https://doi.org/10.1155/2017/6368780
Research Article

Diabetes Is Associated with Increased Autoreactivity of Mannan-Binding Lectin

1Department of Biomedicine, Faculty of Health Sciences, Aarhus University, Wilhelm Meyer’s Allé 4, Aarhus C, Aarhus, Denmark
2Department of Endocrinology and Internal Medicine, Aarhus University Hospital and Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark
3The Danish Diabetes Academy, Odense, Denmark

Correspondence should be addressed to Esben Axelgaard; kd.ua.demoib@xanebse

Received 5 December 2016; Accepted 8 February 2017; Published 28 February 2017

Academic Editor: Marco Songini

Copyright © 2017 Esben Axelgaard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. European Renal Association And European Dialysis and Transplant Association, ERA-EDTA Registry-Annual Report 2013.
  2. USRDS, 2014 USRDS Annual Data Report Volume 2: End-Stage Renal Disease, vol. 2, 2014.
  3. P. Hovind, L. Tarnow, K. Rossing et al., “Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes,” Diabetes Care, vol. 26, no. 4, pp. 1258–1264, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Yokoyama, M. Okudaira, T. Otani et al., “Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan,” Kidney International, vol. 58, no. 1, pp. 302–311, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. T. K. Hansen, S. Thiel, S. T. Knudsen et al., “Elevated levels of mannan-binding lectin in patients with type 1 diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 10, pp. 4857–4861, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Østergaard, T. K. Hansen, S. Thiel, and A. Flyvbjerg, “Complement activation and diabetic vascular complications,” Clinica Chimica Acta, vol. 361, no. 1-2, pp. 10–19, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. T. K. Hansen, L. Tarnow, S. Thiel et al., “Association between mannose-binding lectin and vascular complications in type 1 diabetes,” Diabetes, vol. 53, no. 6, pp. 1570–1576, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Østergaard, S. Thiel, M. Gadjeva, T. K. Hansen, R. Rasch, and A. Flyvbjerg, “Mannose-binding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in mice,” Diabetologia, vol. 50, no. 7, pp. 1541–1549, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Acosta, J. Hettinga, R. Flückiger et al., “Molecular basis for a link between complement and the vascular complications of diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 10, pp. 5450–5455, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Østergaard, M. Bjerre, S. P. Ramachandrarao et al., “Mannan-binding lectin in diabetic kidney disease: the impact of mouse genetics in a type 1 diabetes model,” Experimental Diabetes Research, vol. 2012, Article ID 678381, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. A. Østergaard, M. Bjerre, F. Dagnæs-Hansen, T. K. Hansen, S. Thiel, and A. Flyvbjerg, “Diabetes-induced changes in mannan-binding lectin levels and complement activation in a mouse model of type 1 diabetes,” Scandinavian Journal of Immunology, vol. 77, no. 3, pp. 187–194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. Østergaard, M. M. Ruseva, T. H. Malik et al., “Increased autoreactivity of the complement-activating molecule mannan-binding lectin in a type 1 diabetes model,” Journal of Diabetes Research, vol. 2016, Article ID 1825738, 7 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Ricklin and J. D. Lambris, “Complement in immune and inflammatory disorders: pathophysiological mechanisms,” Journal of Immunology, vol. 190, no. 8, pp. 3831–3838, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Thiel, “Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins,” Molecular Immunology, vol. 44, no. 16, pp. 3875–3888, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. E. Degn and S. Thiel, “Humoral pattern recognition and the complement system,” Scandinavian Journal of Immunology, vol. 78, no. 2, pp. 181–193, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. E. Degn, T. R. Kjaer, R. T. Kidmose et al., “Complement activation by ligand-driven juxtaposition of discrete pattern recognition complexes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 37, pp. 13445–13450, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Endo, H. Ohi, I. Ohsawa, T. Fujita, M. Matsushita, and T. Fujita, “Complement activation through the lectin pathway in patients with Henoch-Schonlein purpura nephritis,” American Journal of Kidney Diseases, vol. 35, no. 3, pp. 401–407, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Møller-Kristensen, W. Wang, M. Ruseva et al., “Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury,” Scandinavian Journal of Immunology, vol. 61, no. 5, pp. 426–434, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Endo, H. Ohi, I. Ohsawa, T. Fujita, M. Matsushita, and T. Fujita, “Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy,” Nephrology Dialysis Transplantation, vol. 13, no. 8, pp. 1984–1990, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Aronson, “Hyperglycemia and the pathobiology of diabetic complications,” Advances in Cardiology, vol. 45, pp. 1–16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Ruseva, M. Kolev, F. Dagnaes-Hansen et al., “Mannan-binding lectin deficiency modulates the humoral immune response dependent on the genetic environment,” Immunology, vol. 127, no. 2, pp. 279–288, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. G. H. Tesch and T. J. Allen, “Rodent models of streptozotocin-induced diabetic nephropathy (methods in renal research),” Nephrology, vol. 12, no. 3, pp. 261–266, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. G. W. Hung, “Stereological methods. Vol. 1: practical methods for biological morphometry: by Ewald R. Weibel, New York/London,” Microchemical Journal, vol. 29, no. 3, pp. 397–399, 1984. View at Publisher · View at Google Scholar
  24. S. V. Petersen, S. Thiel, L. Jensen, R. Steffensen, and J. C. Jensenius, “An assay for the mannan-binding lectin pathway of complement activation,” Journal of Immunological Methods, vol. 257, no. 1-2, pp. 107–116, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. M. V. Nesterenko, M. Tilley, and S. J. Upton, “A simple modification of Blum's silver stain method allows for 30 minite detection of proteins in polyacrylamide gels,” Journal of Biochemical and Biophysical Methods, vol. 28, no. 3, pp. 239–242, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Hovind, T. K. Hansen, L. Tarnow et al., “Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study,” Diabetes, vol. 54, no. 5, pp. 1523–1527, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Saraheimo, C. Forsblom, T. K. Hansen et al., “Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy,” Diabetologia, vol. 48, no. 1, pp. 198–202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. L. H. Bouwman, P. Eerligh, O. T. Terpstra et al., “Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles,” Diabetes, vol. 54, no. 10, pp. 3002–3006, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. J. A. Østergaard, S. Thiel, M. Lajer et al., “Increased all-cause mortality in patients with type 1 diabetes and high-expression mannan-binding lectin genotypes: A 12-Year Follow-up Study,” Diabetes Care, vol. 38, no. 10, pp. 1898–1903, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Matzinger, “Tolerance, danger, and the extended family,” Annual Review of Immunology, vol. 12, pp. 991–1045, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. E. H. Karunanayake, J. R. J. Baker, R. A. Christian, D. J. Hearse, and G. Mellows, “Autoradiographic study of the distribution and cellular uptake of (14C)—streptozotocin in the rat,” Diabetologia, vol. 12, no. 2, pp. 123–128, 1976. View at Publisher · View at Google Scholar · View at Scopus